CSIRO opens 'missing link' lab to develop Australian vaccine pipeline

This is a preview of subscriber content

Subscribe now to continue reading.

“The problem facing our biomedical industry has been that most vaccine and drug candidates needed to be sent overseas to be produced in large quantities for clinical trials, adding burdensome costs that have crushed many Australian businesses and researchers as the invention languishes on the lab bench," saod CSIRO chief executive Dr Larry Marshall. …

Subscribe now to continue reading.

CSIRO opens 'missing link' lab to develop Australian vaccine pipeline

This is a preview of subscriber content

Latest Video

Most Read

HTA reform is fine, but why is the underpinning framework immutable?

Olympian joins call urging vigilance on meningococcal risk

Patient Voice Initiative announces the appointment of new president

The need to correct a profound misconception of what ethical decision-making is and is not

New Australian collaboration to build gene and cell therapy production

New Stories

NDIS keeps growing but signs emerge that reforms are starting to work

USTR launches new investigation, with minimal ambition on pharmaceuticals

New Zealand starting to benefit after lifting advertising prohibition

Mark Butler restates support for health technology assessment reform

Brandon BioCatalyst welcomes the inclusion of its CUREator in new program

Cancer Australia launches research program targeting early-onset cancers

Imugene completes significant placement and launches share purchase plan

Sign In

CSIRO opens 'missing link' lab to develop Australian vaccine pipeline

This is a preview of subscriber content

Latest Video

Most Read

HTA reform is fine, but why is the underpinning framework immutable?

Olympian joins call urging vigilance on meningococcal risk

Patient Voice Initiative announces the appointment of new president

The need to correct a profound misconception of what ethical decision-making is and is not

New Australian collaboration to build gene and cell therapy production

Follow Us

New Stories

NDIS keeps growing but signs emerge that reforms are starting to work

USTR launches new investigation, with minimal ambition on pharmaceuticals

New Zealand starting to benefit after lifting advertising prohibition

Mark Butler restates support for health technology assessment reform

Brandon BioCatalyst welcomes the inclusion of its CUREator in new program

Cancer Australia launches research program targeting early-onset cancers

Imugene completes significant placement and launches share purchase plan